Housed at the UT Arlington campus, the facility will be a regional research center and serve healthcare systems in the six-state region
Placebo responders are different from placebo nonresponders, with implications for the design of clinical trials and the provision of clinical care. Placebo responders, for...
New study results could help physicians choose a therapeutic path for some cancer patients.
The Human Genome Project provided a path for determining the genetic basis of many inherited diseases and neoplasms. So far, various efforts from both...
Insight Genome's whole-genome sequencing gives patients insigth to their risks for specific medical conditions and pharmacogenomic profile.
Many factors drive the next-generation sequencing (NGS) market in regulated environments. Only a few years ago, the throughput and price point did not allow...
Scientists find modified RNA "epitranscriptome" that could be a key regulatory control of gene expression.
DNA methylation could improve outcomes via more accurate diagnoses of indolent or aggressive tumors requiring different treatment regimens
The new blood analysis technique could be used for future outbreak response as a diagnostic tool to help guide treatment strategies.
Nearly half of all hereditary risk factors for coronary artery disease are also associated with entirely different diseases.